Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine Leiomyomas

Background The pathogenesis of uterine leiomyomas, the most common benign tumor in women, remains unclear. Since acquired factors such as obesity, hypertension and early menarche place women at greater risk for uterine leiomyomas, uterine leiomyomas may be associated with epigenetic abnormalities that are caused by unfavorable environmental exposures. Principal Findings Profiles of genome-wide DNA methylation and mRNA expression were investigated in leiomyomas and in myometrium with and without leiomyomas. Profiles of DNA methylation and mRNA expression in the myometrium with and without leiomyomas were quite similar while those in leiomyomas were distinct. We identified 120 genes whose DNA methylation and mRNA expression patterns differed between leiomyomas and the adjacent myometrium. The biological relevance of the aberrantly methylated and expressed genes was cancer process, including IRS1 that is related to transformation, and collagen-related genes such as COL4A1, COL4A2 and COL6A3. We also detected 22 target genes of estrogen receptor (ER) alpha, including apoptosis-related genes, that have aberrant DNA methylation in the promoter, suggesting that the aberrant epigenetic regulation of ER alpha-target genes contributes to the aberrant response to estrogen. Conclusions Aberrant DNA methylation and its related transcriptional aberration were associated with cancer processes, which may represent a critical initial mechanism that triggers transformation of a single tumor stem cell that will eventually develop into a monoclonal leiomyoma tumor. The aberrant epigenetic regulation of ER alpha-target genes also may contribute to the aberrant response to estrogen, which is involved in the development of uterine leiomyomas after menarche.

[1]  D. Coradini,et al.  Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. , 2005, Cancer research.

[2]  A. Reeve,et al.  Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells , 2004, Oncogene.

[3]  C. Sung,et al.  Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma. , 2006, Human pathology.

[4]  J. Byrd,et al.  Quantitative analyses of DAPK1 methylation in AML and MDS , 2012, International journal of cancer.

[5]  E. Wickstrom,et al.  RNAi‐mediated silencing of insulin receptor substrate 1 (IRS‐1) enhances tamoxifen‐induced cell death in MCF‐7 breast cancer cells , 2006, Journal of cellular biochemistry.

[6]  K. Washington,et al.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma , 2008, Gut.

[7]  H. Okano,et al.  Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells , 2007, Proceedings of the National Academy of Sciences.

[8]  C. la Vecchia,et al.  Diet and uterine myomas. , 1999, Obstetrics and gynecology.

[9]  P. Pelicci,et al.  dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53 , 2005, Oncogene.

[10]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[11]  Kohta Ikegami,et al.  Dimethyl Sulfoxide Has an Impact on Epigenetic Profile in Mouse Embryoid Body , 2006, Stem cells.

[12]  L. Aaltonen,et al.  7q deletion mapping and expression profiling in uterine fibroids , 2005, Oncogene.

[13]  S. Soddu,et al.  Growth and Differentiation Signals by the Insulin-like Growth Factor 1 Receptor in Hemopoietic Cells Are Mediated through Different Pathways* , 1999, The Journal of Biological Chemistry.

[14]  A. Skubitz,et al.  Differential gene expression in leiomyosarcoma , 2003, Cancer.

[15]  Jian-Jun Wei,et al.  Genome-Wide DNA Methylation Indicates Silencing of Tumor Suppressor Genes in Uterine Leiomyoma , 2012, PloS one.

[16]  Simak Ali,et al.  Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α , 2001, The Journal of Biological Chemistry.

[17]  M. Szklo,et al.  Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. , 2001, American journal of epidemiology.

[18]  K. Shiota,et al.  Epigenetics by DNA methylation for development of normal and cloned animals. , 2002, Differentiation; research in biological diversity.

[19]  L. Del Valle,et al.  Nuclear IRS‐1 and cancer , 2012, Journal of cellular physiology.

[20]  C. Walker,et al.  Environmental Estrogens Differentially Engage the Histone Methyltransferase EZH2 to Increase Risk of Uterine Tumorigenesis , 2012, Molecular Cancer Research.

[21]  X. Hou,et al.  A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation , 2011, Oncogene.

[22]  R. Malekzadeh,et al.  The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal Cancer , 2012, PloS one.

[23]  E. Surmacz,et al.  Estrogen receptor-α regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells , 2003, Oncogene.

[24]  N. Hattori,et al.  Aberrant DNA methylation status in human uterine leiomyoma. , 2009, Molecular human reproduction.

[25]  C. Tohyama,et al.  Exposure of Mouse Preimplantation Embryos to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Methylation Status of Imprinted Genes H19 and Igf21 , 2004, Biology of reproduction.

[26]  S. Yagi,et al.  Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma. , 2011, The Journal of reproduction and development.

[27]  A. Vecchione,et al.  Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. , 2004, Oncogene.

[28]  N. Bajekal,et al.  Fibroids, infertility and pregnancy wastage. , 2000, Human reproduction update.

[29]  G. Lienhard,et al.  Transforming potential of the insulin receptor substrate 1. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[30]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[31]  Satoshi Tanaka,et al.  Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[32]  M. Szklo,et al.  Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. , 2001, American journal of epidemiology.

[33]  D. Bernard,et al.  NUAK1 links genomic instability and senescence , 2010, Aging.

[34]  N. Hattori,et al.  Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. , 2008, Molecular human reproduction.

[35]  F. Domann,et al.  Epigenetic Regulation of Manganese Superoxide Dismutase Expression in Human Breast Cancer Cells , 2006, Epigenetics.

[36]  M. Spiteri,et al.  Glutathione-S-transferase family of enzymes. , 2001, Mutation research.

[37]  E. Surmacz,et al.  Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. , 2003, Oncogene.

[38]  W. Kibbe,et al.  A collection of bioconductor methods to visualize gene-list annotations , 2010, BMC Research Notes.

[39]  Atul J. Butte,et al.  Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin , 2005, Nature Cell Biology.

[40]  J E Paciga,et al.  Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. , 2001, Cancer research.

[41]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[42]  D. Townsend,et al.  The role of glutathione-S-transferase in anti-cancer drug resistance , 2003, Oncogene.

[43]  Masaaki Oda,et al.  QUMA: quantification tool for methylation analysis , 2008, Nucleic Acids Res..

[44]  J. Mosser,et al.  DNA methylation in glioblastoma: impact on gene expression and clinical outcome , 2010, BMC Genomics.

[45]  Alberto Riva,et al.  The MAPPER2 Database: a multi-genome catalog of putative transcription factor binding sites , 2004, Nucleic Acids Res..

[46]  B. Vollenhoven,et al.  Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. , 2003, Molecular human reproduction.

[47]  W. Catherino,et al.  Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent. , 2010, Fertility and Sterility.

[48]  R. Pieters,et al.  Mu class glutathione S‐transferase mRNA isoform expression in acute lymphoblastic leukaemia , 2003, British journal of haematology.

[49]  A. Vecchione,et al.  Nuclear insulin receptor substrate 1 interacts with estrogen receptor α at ERE promoters , 2004, Oncogene.

[50]  Randal S. Weber,et al.  CpG island methylation profiling in human salivary gland adenoid cystic carcinoma , 2011, Cancer.

[51]  David Bryant,et al.  DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..

[52]  R. Pieters,et al.  Expression of GSTM isoforms in childhood acute lymphoblastoid leukaemia , 2003 .

[53]  M. Mokni,et al.  Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. , 2011, Pathology, research and practice.

[54]  S. Henikoff,et al.  Applying whole-genome studies of epigenetic regulation to study human disease , 2006, Cytogenetic and Genome Research.

[55]  D. Weisenburger,et al.  Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia , 2007, Cell.

[56]  J. Coon,et al.  Role of Stem Cells in Human Uterine Leiomyoma Growth , 2012, PloS one.

[57]  W. Miller,et al.  Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism , 2004, Oncogene.

[58]  J. Chen,et al.  Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling , 2006, Oncogene.

[59]  Alberto Riva,et al.  The MAPPER database: a multi-genome catalog of putative transcription factor binding sites , 2004, Nucleic Acids Res..